The SNIFF trial of nasal insulin for AD will NOT show a statistically significant improvement in CSF Abeta or CSF Abeta/tau ratio over time (i.e., these will NOT be reported as significant by the study investigators).

Created by Porejide on 2015-11-26; known on 2016-12-31

• Porejide estimated 75% on 2015-11-26
• Porejide said “Clinical trial: http://predictionbook.com/predictions/170187” on 2015-11-26
• Porejide said “Note that I know NOTHING about this trial other than public information such as papers. ” on 2015-11-26